Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9957292
Compositions and methods for modulating angiopoietin-like 3 expression
granted -
US 9957281
Benzodiazepine derivatives as RSV inhibitors
granted -
US 9956293
Targeted therapeutics
granted -
US 9957251
Heterocyclic compound
granted -
US 9957214
Multifunctional radical quenchers
granted -
US 9956216
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 9956247
Method of treating lysosomal storage diseases
granted -
US 9956267
Method of treating skeletal dysplasias using vessel dilator
granted -
US 9956188
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 9956178
Methods for delivering insulin preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 9956179
Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
granted -
US 9956172
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
granted -
US 9957569
Recurrent gene fusions in prostate cancer
granted -
US 9957327
Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
granted -
US 9957305
Anti-C. difficile toxin antibodies and associated methods
granted -
US 9956215
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 9957259
Selective HDAC1 and HDAC2 inhibitors
granted -
US 9956282
Bacterial compositions and methods of use thereof for treatment of immune system disorders
granted -
US 9950011
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9950010
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9949932
Formulation of syk inhibitors
granted -
US 9952216
Brain-specific enhancers for cell-based therapy
granted -
US 9951311
Agents and methods to elicit anti-tumor immune response
granted -
US 9951118
Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.